Research Article
Time-Dependent Regional Myocardial Strains in Patients with Heart Failure with a Preserved Ejection Fraction
Table 1
Patient characteristics of the control and HFpEF patients.
| | Patient characteristics | Control () | HFpEF patients () | value |
| | Age (years) | 39 ± 14 | 59 ± 12 | 0.003 | | Gender (male/female) | 2/9 | 5/5 | | | Race (Caucasian/African American/other) | 11/0/0 | 10/0/0 | | | HR (bpm) | 62 ± 8 | 78 ± 13 | 0.004 | | Systolic BP (mmHg) | 116 ± 23 | 124 ± 16 | 0.398 | | Diastolic BP (mmHg) | 69 ± 12 | 72 ± 13 | 0.619 | | BMI (kg/m2) | 26 ± 4 | 29 ± 6 | 0.187 | | Obesity (BMI > 30) () | 2 (18%) | 3 (30%) | | | NYHA Classes II-III () | 0 (0%) | 10 (100%) | | | Diabetes () | 0 (0%) | 6 (60%) | | | Arterial hypertension () | 1 (9%) | 6 (60%) | | | Smoking () | 0 (0%) | 1 (10%) | | | Former smoker () | 3 (27%) |
4 (40%) | | | Hyperlipidemia () | 1 (9%) | 6 (60%) | | | NT-pro-BNP (pg/mL) () | n/a | 797 ± 955 | | | History of coronary artery disease () | 0 (0%) | 9 (90%) | | | Current beta blocker therapy () | 1 (10%) | 10 (100%) | | | Current diuretic therapy () | 0 (0%) | 10 (100%) | |
|
|
Normal range 0–100 pg/mL.
|
